In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...
The vaccine, branded as Penmenvy, combines the immune response-generating components of two of the company's approved ...